skip to Main Content

Biomarker May Have Treatment Implications for Patients With Pancreatic Cancer

Newsfeed image, light gray text on dark gray background
Microsatellite instability (MSI)/mismatch repair deficient (MMR) tumors are rare in patients with pancreatic ductal adenocarcinoma, but its status may have significant implications for treatment, according to a recent study published in Clinical Cancer Research.

After examining samples from 833 patients, researchers found that seven patients had MSI/MMR deficient tumors occurring at a frequency of about 1 percent. Read more . . .

Back To Top